Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0W0ED
|
||||
| Former ID |
DIB009984
|
||||
| Drug Name |
Eflucimibe
|
||||
| Synonyms |
F-12511
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Hyperlipidaemia [ICD9: 272.0-272.4; ICD10:E78] | Discontinued in Phase 2 | [1] | ||
| Company |
Pierre Fabre SA
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C29H43NO2S
|
||||
| Canonical SMILES |
c1(NC(=O)[C@H](c2ccccc2)SCCCCCCCCCCCC)c(c(c(c(c1)C)O)C)<br />C
|
||||
| CAS Number |
CAS 202340-45-2
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Liver carboxylesterase | Target Info | Inhibitor | [2] | |
| KEGG Pathway | Drug metabolism - other enzymes | ||||
| Metabolic pathways | |||||
| Pathway Interaction Database | E2F transcription factor network | ||||
| WikiPathways | NRF2 pathway | ||||
| Nuclear Receptors Meta-Pathway | |||||
| Heroin metabolism | |||||
| Irinotecan Pathway | |||||
| Fluoropyrimidine Activity | |||||
| Phase I biotransformations, non P450 | |||||
| References | |||||
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800011031) | ||||
| REF 2 | Prospects for drug therapy for hyperlipoproteinaemia. Diabete Metab. 1995 Apr;21(2):139-46. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.